AstraZeneca Says AIRSUPRA Now Commercially Available In US As FDA-approved Option For Asthma

(RTTNews) - AstraZeneca (AZN, AZN.L) announces Monday that AIRSUPRA (albuterol/budesonide) is now commercially available in the US by prescription. AIRSUPRA was approved based on the results from two Phase III trials, MANDALA and DENALI. https://www.nasdaq.com/articles/astrazeneca-says-airsupra-now-commercially-available-in-us-as-fda-approved-option-for